Neomyx (Tamsulosin Hydrochloride, Dutasteride)

Tamsulosin Hydrochloride/Dutasteride, the active ingredient in Neomyx, is an Alpha-1 adrenergic antagonist and 5-alpha-reductase inhibitor presented as an oral tablet formulation for oral use. It is indicated for the treatment of benign prostatic hyperplasia in adult men, helping to improve urinary flow and reduce prostate size.

GNH USA supplies Neomyx as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global distribution.

Neomyx is used to manage conditions related to benign prostatic hyperplasia (BPH) and associated lower urinary tract symptoms. - Benign prostatic hyperplasia: improves urinary flow and reduces symptom severity. - Enlarged prostate: decreases prostate volume over time. - Lower urinary tract symptoms due to BPH: lessens frequency, urgency and nocturia.

Neomyx may cause a range of adverse reactions, which are grouped by frequency and severity.

Common Side Effects: - Dizziness or light‑headedness, especially on standing. - Headache. - Abnormal ejaculation or reduced libido. - Nasal congestion or runny nose. - Orthostatic hypotension. - Gastrointestinal discomfort such as nausea.

Serious or Rare Side Effects: - Severe hypotension or syncope. - Intraoperative floppy iris syndrome during cataract surgery. - Allergic reactions including rash, swelling or anaphylaxis. - Hepatic dysfunction or elevated liver enzymes.

Before prescribing Neomyx, clinicians should consider several precautionary measures to ensure patient safety. - Monitor blood pressure: watch for orthostatic changes, especially after initiating therapy. - Assess liver function: dutasteride is metabolized hepatically and may require periodic testing. - Avoid use in patients with known hypersensitivity to either component. - Caution in men scheduled for cataract surgery: increased risk of intraoperative floppy iris syndrome. - Contraindicated in pregnancy and breastfeeding: fetal exposure to dutasteride can cause abnormalities. - Store at room temperature: keep in the original container, protect from moisture and light.

Neomyx can interact with other medicines, and some combinations require avoidance or close monitoring.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may raise dutasteride levels. - Other alpha‑blockers (e.g., prazosin, doxazosin): additive hypotensive effect. - Anticoagulants such as warfarin: potential increase in bleeding risk.

Moderate Interactions (Monitor Closely): - Antihypertensives (ACE inhibitors, ARBs): monitor blood pressure for additive lowering. - Diuretics: watch for electrolyte disturbances and enhanced hypotension. - Rifampin or other CYP3A4 inducers: may reduce dutasteride efficacy.